Clinical Trials Logo

Filter by:
NCT ID: NCT06223880 Recruiting - Clinical trials for Major Depressive Disorder

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Start date: December 27, 2023
Phase: Phase 4
Study type: Interventional

This is a randomized, double-blind, active-controlled, multi-center study to evaluate the efficacy of AXS-05, compared to bupropion, in preventing the relapse of depressive symptoms in subjects with major depressive disorder (MDD) who have responded to treatment with AXS-05.

NCT ID: NCT06223867 Recruiting - Suicidal Ideation Clinical Trials

Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A

Jaspr-PartA
Start date: February 23, 2024
Phase: N/A
Study type: Interventional

This Study will comprehensively evaluate a multi-component suicide prevention technology (Jaspr Health) that facilitates delivery of suicided-related evidence-based practices (EBPs) while replacing wasted waiting time with productive time in the Emergency Departments (EDs). The EBPs satisfy several key performance elements for systems adopting Zero Suicide. A Complementary Randomized Controlled Trial and Real-World Study for Efficacy, Effectiveness, and Implementation Study Design (CREID) will be used

NCT ID: NCT06223828 Recruiting - Critical Illness Clinical Trials

Azithromycin for Critical Asthma - Pediatrics

CR-AZI Kids
Start date: April 2, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

The CR-AZI Study will assess the immunomodulatory effects of Azithromycin for pediatric Critical Asthma.

NCT ID: NCT06223789 Recruiting - Atrial Fibrillation Clinical Trials

VOLT-AF IDE Clinical Study

Start date: April 3, 2024
Phase: N/A
Study type: Interventional

This clinical investigation is intended to demonstrate safety and effectiveness of the Volt™ Pulsed Field Ablation (PFA) Catheter Sensor Enabled™, the Volt™ PFA Generator, Agilis™ NxT Steerable Introducer Dual-Reach™, and EnSite™ X EP System EnSite™ Pulsed Field Ablation Module (for simplicity of reference this device collection will hereafter be referred to as the Volt™ PFA system) for the treatment of symptomatic, recurrent, drug-refractory paroxysmal and persistent atrial fibrillation.

NCT ID: NCT06223672 Recruiting - Clinical trials for Cognitive Impairment

Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study

EFFECT
Start date: February 7, 2024
Phase: N/A
Study type: Interventional

The proposed research is a randomized crossover trial designed to assess changes in postprandial cognitive function and the gut-brain axis in adults with subjective cognitive complaints who consume 1 study snack per day for 1 week.

NCT ID: NCT06223659 Recruiting - Clinical trials for Merkel Cell Carcinoma

EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers

Start date: December 19, 2023
Phase: Phase 2
Study type: Interventional

This phase II trial tests how well EMLA topical cream works in treating pain in patients with skin cancers receiving Technetium 99 injections for a lymphoscintigraphy mapping procedure. A lymphoscintigraphy mapping procedure is used to find the main or lead lymph node (tissue that fight infection) so it can be removed and checked for tumor cells. Using lymphoscintigraphy to highlight and then surgically remove lymph nodes is standard way to treat skin cancer for many patients. The Technetium 99 injections used for lymphoscintigraphy can be briefly painful due to the sensitivity of the nerve endings in the skin. The EMLA topical cream, which contains a numbing medicine to block pain from nerve endings, has been studied in breast cancer patients with a difference in pain reported, but this is the first time it has been studied in patients undergoing lymphoscintigraphy for skin cancer. This study may help researchers learn whether the use of EMLA cream may improve the associated pain at the time of the lymphoscintigraphy procedure.

NCT ID: NCT06223633 Recruiting - Coronary Disease Clinical Trials

PK Papyrus Covered Coronary Stent System

Start date: August 10, 2023
Phase: N/A
Study type: Interventional

The PK Papyrus Covered Coronary Stent System is a coronary stent being used at Methodist Dallas Medical Center for patients with coronary perforations.

NCT ID: NCT06223620 Completed - Clinical trials for SBO - Small Bowel Obstruction

A Multicenter Retrospective Review of Management Strategies in Small Bowel Obstruction

Start date: July 30, 2018
Phase:
Study type: Observational

The objective of the study is to review performance of water soluble contrast study in patients admitted with Small Bowel Obstruction(SBO), will improve quality and safety, and decrease length of stay and morbidity.

NCT ID: NCT06223607 Recruiting - Clinical trials for Baseline Thrombocytopenia

Dual Antiplatelet Therapy (DAPT) in Patients With Baseline Thrombocytopenia

Start date: August 22, 2022
Phase:
Study type: Observational

The use of clopidogrel as part of DAPT will be associated with lower bleeding rates compared to ticagrelor in patients with chronic thrombocytopenia requiring Percutaneous intervention (PCI )with Drug Eluting Stent (DES) or Bare Metal Stint(BMS).

NCT ID: NCT06223594 Recruiting - Acute Pancreatitis Clinical Trials

Evaluation of Intravenous Fluid Therapy Within Dallas Acute Pancreatitis Protocol

Start date: July 17, 2023
Phase:
Study type: Observational

Acute pancreatitis (AP) is a common disease of the gastrointestinal tract that can result in emotional, physical, and financial burdens on the patient.